Key result
Targeted NGS identifies 7 CASQ2 variants in children with CPVT.
Why the study?
Few CASQ2 variants associated with CPVT pathogenesis have been reported, and studies in Asian populations, particularly Chinese individuals, are relatively rare.
Observational (n=6)
This study expands the genetic spectrum of CASQ2-associated CPVT by identifying three novel variants in Chinese children.
Expands CASQ2 variant spectrum in pediatric CPVT; hypothesis-generating and should not yet change practice.
BACKGROUND: Biallelic variants of the CASQ2 are known to cause the autosomal recessive form of catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited disease that predisposes young individuals to syncope and sudden cardiac death. To date, only about 24 CASQ2 variants have been reported in association with CPVT pathogenesis; furthermore, studies in Asians, especially in the Chinese population, are relatively rare. The aim of this study was to detect CASQ2 variants in Chinese patients with CPVT. METHODS: We used targeted next-generation sequencing (NGS) to identify CASQ2 variants in Chinese patients with CPVT. A screening process was performed to prioritize rare variants of potential functional significance. Sanger sequencing was conducted to conform the candidate variants and determine the parental origin. RESULTS: We identified seven different CASQ2 variants, of which three (c.1074_1075delinsC, c.1175_1178delACAG, and c.838+1G>A) have not been previously reported. The variants exhibited autosomal recessive inheritance, and were detected in four unrelated Chinese families with CPVT. They included a nonsense variant c.97C>T (p.R33*) and a missense variant c.748C>T (p.R250C) in Family 1 with three CPVT patients; two heterozygous frameshift variants, c.1074_1075delinsC (p.G359Afs*12) and c.1175_1178delACAG (p.D392Vfs*84), in Family 2 with one CPVT patient; one pathogenic homozygous variant c.98G>A (p.R33Q) of CASQ2 in the CPVT patient of Family 3; and two heterozygous splicing variants, (c.532+1G>A) and (c.838+1G>A), in Family 4 with one CPVT patient. CONCLUSION: To our knowledge, this is the first systematic study of Chinese children with CASQ2 variants. Our work further expands the genetic spectrum of CASQ2-associated CPVT.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) conducted an observational in Catecholaminergic polymorphic ventricular tachycardia (CPVT) (n=6). CASQ2 variants was evaluated on Identification of CASQ2 variants. Targeted next-generation sequencing identified seven different CASQ2 variants, including three novel variants, in six Chinese children with CPVT from four unrelated families.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: